United States · FDA National Drug Code directory

Rabeprazole Sodium

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
51407-184_163e20cc-f058-9b74-e063-6294a90a0a3d
Product NDC
51407-184
Form
TABLET, DELAYED RELEASE
Composition / generic term
Rabeprazole Sodium
Labeler
Golden State Medical Supply, Inc.
Marketing category
ANDA
Marketing start / end (source format)
20131108
Source listing expiry
20261231

Source-listed ingredients

  • RABEPRAZOLE SODIUM — 20 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 500 TABLET, DELAYED RELEASE in 1 BOTTLE (51407-184-05) · 51407-184-05
  • 30 TABLET, DELAYED RELEASE in 1 BOTTLE (51407-184-30) · 51407-184-30
  • 90 TABLET, DELAYED RELEASE in 1 BOTTLE (51407-184-90) · 51407-184-90

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →